Resmetirom For MASH: Approved by US FDA, Increase in Partnerships
The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.
Eli Lilly Zepbound Rezdiffra Resmetirom Madrigal Rezdiffra Zealand Pharma Bristol Myers Squibb Pegbelfermin Novo Nordisk Ozempic
Source: medindia.net